BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2402 related articles for article (PubMed ID: 28622513)

  • 41. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
    Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
    Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma.
    Diaz G; Engle RE; Tice A; Melis M; Montenegro S; Rodriguez-Canales J; Hanson J; Emmert-Buck MR; Bock KW; Moore IN; Zamboni F; Govindarajan S; Kleiner DE; Farci P
    Mol Cancer Res; 2018 Sep; 16(9):1406-1419. PubMed ID: 29858376
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
    Li S; Mao M
    Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-192-5p Silencing by Genetic Aberrations Is a Key Event in Hepatocellular Carcinomas with Cancer Stem Cell Features.
    Gu Y; Wei X; Sun Y; Gao H; Zheng X; Wong LL; Jin L; Liu N; Hernandez B; Peplowska K; Zhao X; Zhan QM; Feng XH; Tang ZY; Ji J
    Cancer Res; 2019 Mar; 79(5):941-953. PubMed ID: 30530815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
    Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
    Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features.
    Li X; Xu W; Kang W; Wong SH; Wang M; Zhou Y; Fang X; Zhang X; Yang H; Wong CH; To KF; Chan SL; Chan MTV; Sung JJY; Wu WKK; Yu J
    Theranostics; 2018; 8(6):1740-1751. PubMed ID: 29556353
    [No Abstract]   [Full Text] [Related]  

  • 48. The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma.
    He XX; Kuang SZ; Liao JZ; Xu CR; Chang Y; Wu YL; Gong J; Tian DA; Guo AY; Lin JS
    Mol Biosyst; 2015 Feb; 11(2):532-9. PubMed ID: 25424171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic Targeted Sequencing Panel for Hepatocellular Carcinoma Genomic Screening.
    Paradiso V; Garofoli A; Tosti N; Lanzafame M; Perrina V; Quagliata L; Matter MS; Wieland S; Heim MH; Piscuoglio S; Ng CKY; Terracciano LM
    J Mol Diagn; 2018 Nov; 20(6):836-848. PubMed ID: 30142445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis.
    Wu T; Luo G; Lian Q; Sui C; Tang J; Zhu Y; Zheng B; Li Z; Zhang Y; Zhang Y; Bao J; Hu J; Shen S; Yang Z; Wu J; Wang K; Zhao Y; Yang S; Wang S; Qiu X; Wang W; Wu X; Wang H; Gu J; Chen L
    Hepatology; 2021 Dec; 74(6):3249-3268. PubMed ID: 34343359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection.
    Ma X; Gu J; Wang K; Zhang X; Bai J; Zhang J; Liu C; Qiu Q; Qu K
    Sci Rep; 2019 May; 9(1):7073. PubMed ID: 31068611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma.
    Chan AW; Zhang Z; Chong CC; Tin EK; Chow C; Wong N
    J Pathol; 2019 Oct; 249(2):166-172. PubMed ID: 31168847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
    Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.
    Allain C; Angenard G; Clément B; Coulouarn C
    Cancer Res; 2016 Nov; 76(21):6374-6381. PubMed ID: 27634755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.
    Ye C; Tao R; Cao Q; Zhu D; Wang Y; Wang J; Lu J; Chen E; Li L
    Int J Oncol; 2016 Aug; 49(2):589-602. PubMed ID: 27221337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas.
    Amaddeo G; Cao Q; Ladeiro Y; Imbeaud S; Nault JC; Jaoui D; Gaston Mathe Y; Laurent C; Laurent A; Bioulac-Sage P; Calderaro J; Zucman-Rossi J
    Gut; 2015 May; 64(5):820-9. PubMed ID: 25021421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 121.